Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcome and prognostic factors in cerebellar glioblastoma multiforme in adults: a retrospective study from the Rare Cancer Network.
Weber DC, Miller RC, Villà S, Hanssens P, Baumert BG, Castadot P, Varlet P, Abacioglu U, Igdem S, Szutowicz E, Nishioka H, Hofer S, Rutz HP, Ozsahin M, Taghian A, Mirimanoff RO. Weber DC, et al. Among authors: abacioglu u. Int J Radiat Oncol Biol Phys. 2006 Sep 1;66(1):179-86. doi: 10.1016/j.ijrobp.2006.04.035. Epub 2006 Jul 11. Int J Radiat Oncol Biol Phys. 2006. PMID: 16814953
Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer Network.
Omlin A, Amichetti M, Azria D, Cole BF, Fourneret P, Poortmans P, Naehrig D, Miller RC, Krengli M, Gutierrez Miguelez C, Morgan D, Goldberg H, Scandolaro L, Gastelblum P, Ozsahin M, Dohr D, Christie D, Oppitz U, Abacioglu U, Gruber G. Omlin A, et al. Among authors: abacioglu u. Lancet Oncol. 2006 Aug;7(8):652-6. doi: 10.1016/S1470-2045(06)70765-3. Lancet Oncol. 2006. PMID: 16887482
Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN).
Goldberg H, Miller RC, Abdah-Bortnyak R, Steiner M, Yildiz F, Meirovitz A, Villà S, Poortmans PM, Azria D, Zidan J, Ozsahin M, Abacioglu U, Gold DG, Amit A, Lavie O, Atahan IL, Kuten A; Rare Cancer Network. Goldberg H, et al. Among authors: abacioglu u. Gynecol Oncol. 2008 Feb;108(2):298-305. doi: 10.1016/j.ygyno.2007.10.037. Epub 2007 Dec 21. Gynecol Oncol. 2008. PMID: 18096209
Treatment results of 165 pediatric patients with non-metastatic nasopharyngeal carcinoma: a Rare Cancer Network study.
Ozyar E, Selek U, Laskar S, Uzel O, Anacak Y, Ben-Arush M, Polychronopoulou S, Akman F, Wolden SL, Sarihan S, Miller RC, Ozsahin M, Abacioğlu U, Martin M, Caloglu M, Scandolaro L, Szutowicz E, Atahan IL. Ozyar E, et al. Among authors: abacioglu u. Radiother Oncol. 2006 Oct;81(1):39-46. doi: 10.1016/j.radonc.2006.08.019. Epub 2006 Sep 11. Radiother Oncol. 2006. PMID: 16965827
Curative external beam radiotherapy in patients over 80 years of age with localized prostate cancer: a retrospective rare cancer network study.
Nguyen TD, Azria D, Brochon D, Poortmans P, Miller RC, Scandolaro L, Majewski W, Krengli M, Abacioglu U, Moretti L, Villa S, Akyol F, Jovenin N. Nguyen TD, et al. Among authors: abacioglu u. Crit Rev Oncol Hematol. 2010 Apr;74(1):66-71. doi: 10.1016/j.critrevonc.2009.04.004. Epub 2009 May 5. Crit Rev Oncol Hematol. 2010. PMID: 19419885
Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study.
Kocher M, Soffietti R, Abacioglu U, Villà S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Carrie C, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Collette S, Collette L, Mueller RP. Kocher M, et al. Among authors: abacioglu u. J Clin Oncol. 2011 Jan 10;29(2):134-41. doi: 10.1200/JCO.2010.30.1655. Epub 2010 Nov 1. J Clin Oncol. 2011. PMID: 21041710 Free PMC article. Clinical Trial.
A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results.
Soffietti R, Kocher M, Abacioglu UM, Villa S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Carrie C, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Mueller RP, Tridello G, Collette L, Bottomley A. Soffietti R, et al. J Clin Oncol. 2013 Jan 1;31(1):65-72. doi: 10.1200/JCO.2011.41.0639. Epub 2012 Dec 3. J Clin Oncol. 2013. PMID: 23213105 Free article. Clinical Trial.
Urethra-Sparing Stereotactic Body Radiation Therapy for Prostate Cancer: Quality Assurance of a Randomized Phase 2 Trial.
Jaccard M, Zilli T, Dubouloz A, Escude L, Jorcano S, Linthout N, Bral S, Verbakel W, Bruynzeel A, Björkqvist M, Minn H, Tsvang L, Symon Z, Lencart J, Oliveira A, Ozen Z, Abacioglu U, Pérez-Moreno JM, Rubio C, Rouzaud M, Miralbell R. Jaccard M, et al. Among authors: abacioglu u. Int J Radiat Oncol Biol Phys. 2020 Nov 15;108(4):1047-1054. doi: 10.1016/j.ijrobp.2020.06.002. Epub 2020 Jun 12. Int J Radiat Oncol Biol Phys. 2020. PMID: 32535161 Clinical Trial.
Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO).
Soffietti R, Abacioglu U, Baumert B, Combs SE, Kinhult S, Kros JM, Marosi C, Metellus P, Radbruch A, Villa Freixa SS, Brada M, Carapella CM, Preusser M, Le Rhun E, Rudà R, Tonn JC, Weber DC, Weller M. Soffietti R, et al. Among authors: abacioglu u. Neuro Oncol. 2017 Feb 1;19(2):162-174. doi: 10.1093/neuonc/now241. Neuro Oncol. 2017. PMID: 28391295 Free PMC article.
63 results